Current diagnostic and treatment strategies for adenomyosis

References

• Benson RC, Sneeden VD. Adenomyosis: a reappraisal of symptomatology. Am. J. Obstet. Gynecol.76, 1044–1057 (1958).
   PubMed Web of Science ®Google Scholar
• Azziz R. Adenomyosis: current perspectives. Obstet. Gynecol. Clin. North Am.16, 221–235 (1989).
   PubMed Web of Science ®Google Scholar
• Rokitansky K. Ueber uterusdruesen-neubildung. Z. Gesellschaft. Aerzte. Wien.16, 577–581 (1860).
   Google Scholar
• Uduwela AS, Perera MA, Aiqing L, Fraser IS. Endometrial-myometrial interface: relationship to adenomyosis and changes in pregnancy. Obstet. Gynecol. Surv.55, 390–400 (2000).
   PubMed Web of Science ®Google Scholar
• Devlieger R, D’Hooghe T, Timmerman D. Uterine adenomyosis in the infertility clinic. Hum. Reprod. Update9, 139–147 (2003).
   PubMed Web of Science ®Google Scholar
• deSouza NM, Brosens JJ, Schwieso JE, Paraschos T, Winston RM. The potential value of magnetic resonance imaging in infertility. Clin. Radiol.50, 75–79 (1995).
   Google Scholar
• Ferenczy A. Pathophysiology of adenomyosis. Hum. Reprod. Update4, 312–322 (1998).
   PubMed Web of Science ®Google Scholar
• Nisolle M, Donnez J. Peritoneal endometriosis, ovarian endometriosis, and adenomyotic nodules of the rectovaginal septum are three different entities. Fertil. Steril.68, 585–596 (1997).
   PubMed Web of Science ®Google Scholar
• Brosens JJ, de Souza NM, Barker FG. Uterine junctional zone: function and disease. Lancet346, 558–560 (1995).
   PubMed Web of Science ®Google Scholar
• Levgur M, Abadi MA, Tucker A. Adenomyosis: symptoms, histology, and pregnancy terminations. Obstet. Gynecol.95, 688–691 (2000).
   PubMed Web of Science ®Google Scholar
• Mori T, Ohta Y, Nagasawa H. Ultrastructural changes in uterine myometrium of mice with experimentally-induced adenomyosis. Experientia40, 1385–1387 (1984).
   Google Scholar
• Ascher SM, Johnson JC, Barnes WA, Bae CJ, Patt RH, Zeman RK. MR imaging appearance of the uterus in postmenopausal women receiving tamoxifen therapy for breast cancer: histopathologic correlation. Radiology200, 105–110 (1996).
   PubMed Web of Science ®Google Scholar
• Cohen I, Beyth Y, Tepper R et al. Adenomyosis in postmenopausal breast cancer patients treated with tamoxifen: a new entity? Gynecol. Oncol.58, 86–91 (1995).
   PubMed Web of Science ®Google Scholar
• Miyamoto N, Mandai M, Suzuma I, Suzuma K, Kobayashi K, Honda Y. Estrogen protects against cellular infiltration by reducing the expressions of E-selectin and IL-6 in endotoxin-induced uveitis. J. Immunol.163, 374–379 (1999).
   PubMed Web of Science ®Google Scholar
• Gaetje R, Kotzian S, Herrmann G, Baumann R, Starzinski-Powitz A. Invasiveness of endometriotic cells in vitro. Lancet346, 1463–1464 (1995).
   PubMed Web of Science ®Google Scholar
• Yang JH, Chen MJ, Chen HF, Lee TH, Ho HN, Yang YS. Decreased expression of killer cell inhibitory receptors on natural killer cells in eutopic endometrium in women with adenomyosis. Hum. Reprod.19, 1974–1978 (2004).
   PubMed Web of Science ®Google Scholar
• Yang JH, Wu MY, Chang DY, Chang CH, Yang YS, Ho HN. Increased interleukin-6 messenger RNA expression in macrophage-cocultured endometrial stromal cells in adenomyosis. Am. J. Reprod. Immunol.55, 181–187 (2006).
   Google Scholar
• Goldberger MA, Marshak RH, Hermel M. Roentgen diagnosis of adenomyosis uteri. Am. J. Obstet. Gynecol.57, 563–568 (1949).
   Google Scholar
• Marshak RH, Eliasoph J. The roentgen findings in adenomyosis. Radiology64, 846–851 (1955).
   Google Scholar
• Slezak P, Tillinger KG. The incidence and clinical importance of hysterographic evidence of cavities in the uterine wall. Radiology118, 581–586 (1976).
   Google Scholar
• Popp LW, Schwiedessen JP, Gaetje R. Myometrial biopsy in the diagnosis of adenomyosis uteri. Am. J. Obstet. Gynecol.169, 546–549 (1993).
   PubMed Web of Science ®Google Scholar
• McCausland AM. Hysteroscopic myometrial biopsy: its use in diagnosing adenomyosis and its clinical application. Am. J. Obstet. Gynecol.166, 1619–1626; discussion 1626–1618 (1992).
   Google Scholar
• Brosens JJ, Barker FG. The role of myometrial needle biopsies in the diagnosis of adenomyosis. Fertil. Steril.63, 1347–1349 (1995).
   PubMed Web of Science ®Google Scholar
• Walsh JW, Taylor KJ, Rosenfield AT. Gray scale ultrasonography in the diagnosis of endometriosis and adenomyosis. Am. J. Roentgenol.132, 87–90 (1979).
   PubMed Web of Science ®Google Scholar
• Bohlman ME, Ensor RE, Sanders RC. Sonographic findings in adenomyosis of the uterus. Am. J. Roentgenol.148, 765–766 (1987).
   PubMed Web of Science ®Google Scholar
• Siedler D, Laing FC, Jeffrey RB Jr, Wing VW. Uterine adenomyosis. A difficult sonographic diagnosis. J. Ultrasound Med.6, 345–349 (1987).
   Google Scholar
• Reinhold C, Tafazoli F, Wang L. Imaging features of adenomyosis. Hum. Reprod. Update4, 337–349 (1998).
   PubMed Web of Science ®Google Scholar
• Ascher SM, Arnold LL, Patt RH et al. Adenomyosis: prospective comparison of MR imaging and transvaginal sonography. Radiology190, 803–806 (1994).
   PubMed Web of Science ®Google Scholar
• Brosens JJ, De Souza NM, Barker FG, Paraschos T, Winston RM. Endovaginal ultrasonography in the diagnosis of adenomyosis uteri: identifying the predictive characteristics. Br. J. Obstet. Gynaecol.102, 471–474 (1995).
   PubMedGoogle Scholar
• Fedele L, Bianchi S, Raffaelli R, Portuese A, Dorta M. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil. Steril.68, 426–429 (1997).
   PubMed Web of Science ®Google Scholar
• Reinhold C, Atri M, Mehio A, Zakarian R, Aldis AE, Bret PM. Diffuse uterine adenomyosis: morphologic criteria and diagnostic accuracy of endovaginal sonography. Radiology197, 609–614 (1995).
   PubMed Web of Science ®Google Scholar
• Atri M, Reinhold C, Mehio AR, Chapman WB, Bret PM. Adenomyosis: US features with histologic correlation in an in-vitro study. Radiology215, 783–790 (2000).
   PubMed Web of Science ®Google Scholar
• Bazot M, Cortez A, Darai E et al. Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology. Hum. Reprod.16, 2427–2433 (2001).
   PubMed Web of Science ®Google Scholar
• Fedele L, Bianchi S, Dorta M, Arcaini L, Zanotti F, Carinelli S. Transvaginal ultrasonography in the diagnosis of diffuse adenomyosis. Fertil. Steril.58, 94–97 (1992).
   PubMed Web of Science ®Google Scholar
• Reinhold C, McCarthy S, Bret PM et al. Diffuse adenomyosis: comparison of endovaginal US and MR imaging with histopathologic correlation. Radiology199, 151–158 (1996).
   PubMed Web of Science ®Google Scholar
• Perrot N, Frey I, Mergui JL, Bazot M, Uzan M, Uzan S. Picture of the month. Adenomyosis: power Doppler findings. Ultrasound Obstet. Gynecol.17, 177–178 (2001).
   PubMed Web of Science ®Google Scholar
• Lee JK, Gersell DJ, Balfe DM, Worthington JL, Picus D, Gapp G. The uterus: in vitro MR-anatomic correlation of normal and abnormal specimens. Radiology157, 175–179 (1985).
   PubMedGoogle Scholar
• Mark AS, Hricak H, Heinrichs LW et al. Adenomyosis and leiomyoma: differential diagnosis with MR imaging. Radiology163, 527–529 (1987).
   PubMed Web of Science ®Google Scholar
• Togashi K, Ozasa H, Konishi I et al. Enlarged uterus: differentiation between adenomyosis and leiomyoma with MR imaging. Radiology171, 531–534 (1989).
   PubMed Web of Science ®Google Scholar
• Togashi K, Nishimura K, Itoh K et al. Adenomyosis: diagnosis with MR imaging. Radiology166, 111–114 (1988).
   PubMed Web of Science ®Google Scholar
• Hricak H, Finck S, Honda G, Goranson H. MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images. Am. J. Roentgenol.158, 1043–1050 (1992).
   PubMed Web of Science ®Google Scholar
• Outwater EK, Siegelman ES, Van Deerlin V. Adenomyosis: current concepts and imaging considerations. Am. J. Roentgenol.170, 437–441 (1998).
   PubMedGoogle Scholar
• Olson MC, Posniak HV, Tempany CM, Dudiak CM. MR imaging of the female pelvic region. Radiographics12, 445–465 (1992).
   Google Scholar
• Turnbull LW, Jumaa A, Bowsley SJ, Dhawan S, Horsman A, Killick SR. Magnetic resonance imaging of the uterus after endometrial resection. Br. J. Obstet. Gynaecol.104, 934–938 (1997).
   PubMedGoogle Scholar
• McCausland AM, McCausland VM. Partial rollerball endometrial ablation: a modification of total ablation to treat menorrhagia without causing complications from intrauterine adhesions. Am. J. Obstet. Gynecol.180, 1512–1521 (1999).
   Google Scholar
• Marjoribanks J, Proctor ML, Farquhar C. Nonsteroidal anti-inflammatory drugs for primary dysmenorrhoea. Cochrane Database Syst. Rev.4, CD001751 (2003).
   Google Scholar
• Allen C, Hopewell S, Prentice A. Non-steroidal anti-inflammatory drugs for pain in women with endometriosis. Cochrane Database Syst. Rev.19(4), CD004753 (2005).
   Google Scholar
• Rice VM. Conventional medical therapies for endometriosis. Ann. NY Acad. Sci.955, 343–352; discussion 389–393, 396–406 (2002).
   PubMed Web of Science ®Google Scholar
• Vercellini P, Fedele L, Pietropaolo G, Frontino G, Somigliana E, Crosignani PG. Progestogens for endometriosis: forward to the past. Hum. Reprod. Update9, 387–396 (2003).
   PubMed Web of Science ®Google Scholar
• Vercellini P, Frontino G, De Giorgi O, Pietropaolo G, Pasin R, Crosignani PG. Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil. Steril.80, 560–563 (2003).
   PubMed Web of Science ®Google Scholar
• WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. Lancet349, 1202–1209 (1997).
   PubMed Web of Science ®Google Scholar
• Luciano AA, Turksoy RN, Carleo J. Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. Obstet. Gynecol.72, 323–327 (1988).
   PubMed Web of Science ®Google Scholar
• Schweppe KW. Current place of progestins in the treatment of endometriosis-related complaints. Gynecol. Endocrinol.15(Suppl. 6), 22–28 (2001).
   PubMedGoogle Scholar
• Blei F, Wilson EL, Mignatti P, Rifkin DB. Mechanism of action of angiostatic steroids: suppression of plasminogen activator activity via stimulation of plasminogen activator inhibitor synthesis. J. Cell Physiol.155, 568–578 (1993).
   PubMed Web of Science ®Google Scholar
• Mittal KR, Barwick KW. Endometrial adenocarcinoma involving adenomyosis without true myometrial invasion is characterized by frequent preceding estrogen therapy, low histologic grades, and excellent prognosis. Gynecol. Oncol.49, 197–201 (1993).
   PubMed Web of Science ®Google Scholar
• Critchley HO, Wang H, Kelly RW, Gebbie AE, Glasier AF. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Hum. Reprod.13, 1210–1217 (1998).
   PubMed Web of Science ®Google Scholar
• Nilsson CG, Haukkamaa M, Vierola H, Luukkainen T. Tissue concentrations of levonorgestrel in women using a levonorgestrel-releasing IUD. Clin. Endocrinol. (Oxf.)17, 529–536 (1982).
   PubMed Web of Science ®Google Scholar
• Cameron IT, Leask R, Kelly RW, Baird DT. The effects of danazol, mefenamic acid, norethisterone and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandins34, 99–110 (1987).
   PubMed Web of Science ®Google Scholar
• Fong YF, Singh K. Medical treatment of a grossly enlarged adenomyotic uterus with the levonorgestrel-releasing intrauterine system. Contraception60, 173–175 (1999).
   PubMed Web of Science ®Google Scholar
• McGavigan CJ, Cameron IT. The Mirena levonorgestrel system. Drugs Today (Barc.)39, 973–984 (2003).
   PubMed Web of Science ®Google Scholar
• Rotondi M, Labriola D, Ammaturo FP et al. Depot leuprorelin acetate versus danazol in the treatment of infertile women with symptomatic endometriosis. Eur. J. Gynaecol. Oncol.23, 523–526 (2002).
   PubMed Web of Science ®Google Scholar
• Valle RF, Sciarra JJ. Endometriosis: treatment strategies. Ann. NY Acad. Sci.997, 229–239 (2003).
   PubMed Web of Science ®Google Scholar
• Ingerslev M. Danazol: an antigonadotrophic agent in the treatment of recurrent pelvic and intestinal endometriosis. Acta. Obstet. Gynecol. Scand.56, 343–346 (1977).
   Web of Science ®Google Scholar
• Lauersen NH, Wilson KH, Birnbaum S. Danazol: an antigonadotropic agent in the treatment of pelvic endometriosis. Am. J. Obstet. Gynecol.123, 742–747 (1975).
   Google Scholar
• Ota H, Maki M, Shidara Y et al. Effects of danazol at the immunologic level in patients with adenomyosis, with special reference to autoantibodies: a multi-center cooperative study. Am. J. Obstet. Gynecol.167, 481–486 (1992).
   Google Scholar
• Singtripop T, Mori T, Sakamoto S, Sassa S, Park MK, Kawashima S. Suppression of the development of uterine adenomyosis by danazol treatment in mice. Life Sci.51, 1119–1125 (1992).
   Google Scholar
• Igarashi M, Abe Y, Fukuda M et al. Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device. Fertil. Steril.74, 412–413 (2000).
   PubMed Web of Science ®Google Scholar
• Tamaoka Y, Orikasa H, Sumi Y et al. Direct effect of danazol on endometrial hyperplasia in adenomyotic women: treatment with danazol containing intrauterine device. Hum. Cell13, 127–133 (2000).
   Google Scholar
• Child TJ, Tan SL. Endometriosis: aetiology, pathogenesis and treatment. Drugs61, 1735–1750 (2001).
   PubMed Web of Science ®Google Scholar
• Filicori M, Flamigni C, Cognigni G et al. Comparison of the suppressive capacity of different depot gonadotropin-releasing hormone analogs in women. J. Clin. Endocrinol. Metab.77, 130–133 (1993).
   Google Scholar
• Nelson JR, Corson SL. Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist: a case report. Fertil. Steril.59, 441–443 (1993).
   PubMed Web of Science ®Google Scholar
• Grow DR, Filer RB. Treatment of adenomyosis with long-term GnRH analogues: a case report. Obstet. Gynecol.78, 538–539 (1991).
   PubMed Web of Science ®Google Scholar
• Imaoka I, Ascher SM, Sugimura K et al. MR imaging of diffuse adenomyosis changes after GnRH analog therapy. J. Magn. Reson. Imag.15, 285–290 (2002).
   PubMed Web of Science ®Google Scholar
• Caird LE, West CP, Lumsden MA, Hannan WJ, Gow SM. Medroxyprogesterone acetate with Zoladex for long-term treatment of fibroids: effects on bone density and patient acceptability. Hum. Reprod.12, 436–440 (1997).
   Google Scholar
• McCausland V, McCausland A. The response of adenomyosis to endometrial ablation/resection. Hum. Reprod. Update4, 350–359 (1998).
   PubMedGoogle Scholar
• Wood C. Surgical and medical treatment of adenomyosis. Hum. Reprod. Update4, 323–336 (1998).
   PubMed Web of Science ®Google Scholar
• McCausland AM, McCausland VM. Depth of endometrial penetration in adenomyosis helps determine outcome of rollerball ablation. Am. J. Obstet. Gynecol.174, 1786–1793; 1793–1784 (1996).
   PubMed Web of Science ®Google Scholar
• Bradley LD. Complications in hysteroscopy: prevention, treatment and legal risk. Curr. Opin. Obstet. Gynecol.14, 409–415 (2002).
   PubMed Web of Science ®Google Scholar
• Phillips DR, Nathanson HG, Milim SJ, Haselkorn JS. Laparoscopic bipolar coagulation for the conservative treatment of adenomyomata. J. Am. Assoc. Gynecol. Laparosc.4, 19–24 (1996).
   Google Scholar
• Wood C, Maher P, Hill D. Biopsy diagnosis and conservative surgical treatment of adenomyosis. Aust. NZ J. Obstet. Gynaecol.33, 319–321 (1993).
   PubMed Web of Science ®Google Scholar
• Morita M, Asakawa Y, Nakakuma M, Kubo H. Laparoscopic excision of myometrial adenomyomas in patients with adenomyosis uteri and main symptoms of severe dysmenorrhea and hypermenorrhea. J. Am. Assoc. Gynecol. Laparosc.11, 86–89 (2004).
   PubMedGoogle Scholar
• Siskin GP, Englander M, Stainken BF, Ahn J, Dowling K, Dolen EG. Embolic agents used for uterine fibroid embolization. Am. J. Roentgenol.175, 767–773 (2000).
   PubMed Web of Science ®Google Scholar
• Smith SJ, Sewall LE, Handelsman A. A clinical failure of uterine fibroid embolization due to adenomyosis. J. Vasc. Interv. Radiol.10, 1171–1174 (1999).
   Google Scholar
• Kim MD, Won JW, Lee DY, Ahn CS. Uterine artery embolization for adenomyosis without fibroids. Clin. Radiol.59, 520–526 (2004).
   PubMed Web of Science ®Google Scholar
• Siskin GP, Tublin ME, Stainken BF, Dowling K, Dolen EG. Uterine artery embolization for the treatment of adenomyosis: clinical response and evaluation with MR imaging. Am. J. Roentgenol.177, 297–302 (2001).
   PubMed Web of Science ®Google Scholar
• Toh CH, Wu CH, Tsay PK et al. Uterine artery embolization for symptomatic uterine leiomyoma and adenomyosis. J. Formos. Med. Assoc.102, 701–706 (2003).
   Google Scholar
• Ter Haar GR. High intensity focused ultrasound for the treatment of tumors. Echocardiography18, 317–322 (2001).
   PubMed Web of Science ®Google Scholar
• Vaezy S, Fujimoto VY, Walker C, Martin RW, Chi EY, Crum LA. Treatment of uterine fibroid tumors in a nude mouse model using high-intensity focused ultrasound. Am. J. Obstet. Gynecol.183, 6–11 (2000).
   PubMed Web of Science ®Google Scholar
• Wood C, Maher PJ. Laparoscopic hysterectomy. Baillieres Clin. Gynaecol.11, 111–136 (1997).
   Google Scholar
• Zhou YF, Matsuda M, Mori T, Sakamoto S, Mitamura T. Effects of mifepristone (RU486) treatment on the development of uterine adenomyosis induced by pituitary grafting in mice. Life Sci.67, 2713–2720 (2000).
   PubMed Web of Science ®Google Scholar
• Mori T, Nakahashi K, Kyokuwa M, Yamasaki S, Nagasawa H. A matrix metalloproteinase inhibitor, ONO-4817, retards the development of mammary tumor and the progression of uterine adenomyosis in mice. Anticancer Res.22, 3985–3988 (2002).
   PubMed Web of Science ®Google Scholar
• Mori T, Yamasaki S, Masui F, Matsuda M, Sasabe H, Zhou YF. Suppression of the development of experimentally induced uterine adenomyosis by a novel matrix metalloproteinase inhibitor, ONO-4817, in mice. Exp. Biol. Med. (Maywood)226, 429–433 (2001).
   Google Scholar
• Kimmins S, Russell GL, Lim HC, Hall BK, MacLaren LA. The effects of estrogen, its antagonist ICI 182, 780, and interferon-tau on the expression of estrogen receptors and integrin α V β 3 on cycle day 16 in bovine endometrium. Reprod. Biol. Endocrinol.1, 38 (2003).
   PubMedGoogle Scholar
• Waterton JC, Breen SA, Dukes M, Horrocks M, Wadsworth PF. A case of adenomyosis in a pigtailed monkey diagnosed by magnetic resonance imaging and treated with the novel pure antiestrogen, ICI 182,780. Lab. Anim. Sci.43, 247–251 (1993).
   Google Scholar